CDK9 and Familial prostate cancer: To test if OGT regulates MRE11 chromatin-association, we isolated nuclear/cytosolic- and chromatin-fractions from prostate cancer cells treated with CDK9 inhibitor in the presence and absence of the OGT inhibitor OSMI-4.